20th International Congress » Parkinson's disease: Neuroimaging and neurophysiology

12:00pm-1:30pm

A cognitive fMRI study of non-manifesting LRRK2 and GBA carriers

A. Thaler, N. Bregman, A. Mirelman, T. Gurevich, M. Gana-Weiss, A. Orr-Urtreger, T. Hendler, N. Giladi (Tel-Aviv, Israel)

12:00pm-1:30pm

A longitudinal study of functional deterioration of primary olfactory cortex in early-stage Parkinson’s disease

J. Wang, Z. Mosher, T. Subramanian, Q.X. Yang (Hershey, PA, USA)

12:00pm-1:30pm

Alterations in muscle synergies in early stage Parkinson’s disease

J.F. Daneault, G. Vergara-Diaz, C. Adans-Dester, G. Ferreira-Carvalho, V.C.K. Cheung, P. Bonato (Charlestown, MA, USA)

12:00pm-1:30pm

Altered brain activation in complex walking conditions in patients with Parkinson’s disease

I. Maidan, K. Rosenberg-Katz, Y. Jacob, N. Giladi, J.E. Deutsch, A. Mirelman, J.M. Hausdorff (Tel Aviv, Israel)

12:00pm-1:30pm

Altered resting-state functional interhemispheric connectivity in Parkinson’s disease

X. Dan, S. Lin, A. Liu, Z. Wang, M.J. McKeown, P. Chan (Beijing, People's Republic of China)

12:00pm-1:30pm

Assessment of brainstem function with blink reflex variations in Parkinson’s disease

D. Weise, C. Pargac, J.J. Rumpf, C. Fricke, J. Classen (Leipzig, Germany)

12:00pm-1:30pm

Behavioral and neuroimaging effects of LSVT-BIG and conventional physiotherapy in Parkinson’s disease

F. Schaible, F. Schwartz, T. v. Eimeren, C. Eggers (Köln, Germany)

12:00pm-1:30pm

Botulinum toxin treatment of freezing of gait in Parkinson’s disease patients as reflected in functional magnetic resonance imaging of leg movement

M. Vaštík, P. Hok, P. Hluštík, P. Kanovský, Z. Tüdös (Olomouc, Czech Republic)

12:00pm-1:30pm

Brain iron levels in Parkinson’s disease by postmortem and MRI measurements: A systematic review and meta-analysis

J.Y. Wang, Q.Q. Zhuang, L.B. Zhu, H. Zhu, T. Li, X. Zhang, J.H. Zhu (Wenzhou, People's Republic of China)

12:00pm-1:30pm

Brain mechanisms underlying visual processing in Parkinson’s disease

I. Rektorova, N. Elfmarkova, M. Gajdos, R. Marecek, S. Rapcsak (Brno, Czech Republic)

12:00pm-1:30pm

Changes of brain structure and cognition in individuals with possible prodromal Parkinson’s disease

M. Heldmann, J. Heeren, L. Rauch, C. Klein, T.F. Münte, M. Kasten, N. Brüggemann (Lübeck, Germany)

12:00pm-1:30pm

Characterization and quantitative analysis of prelemniscal radiations in Parkinson´s disease

M.G. Garcia-Gomar, I. Vaca-Palomares, M. Esqueda, J. Soto, J.D. Tournier, L. Concha, F. Velasco (Queretaro, Mexico)

12:00pm-1:30pm

Combined effects of visual and auditory cues on gait initiation in Parkinson’s disease

T. Hashimoto, H. Sato (Matsumoto, Japan)

12:00pm-1:30pm

Comparative analysis of clinical and neuroimaging features of parkinsonism and dementia of Alzheimer’s type

D. Tolibov, G. Rakhimbaeva (Tashkent, Uzbekistan)

12:00pm-1:30pm

Comparison of DAT and DOPA PET tracer for assessing severity and progression in patients with Parkinson’s disease

W. Li, N.P. Lao-Kaim, A.A. Roussakis, A. Martin-Bastida, C. Loane, N. Valle-Guzman, Z. Kefalopoulou, M. Politis, T. Foltynie, R.A. Barker, P. Piccini (London, United Kingdom)

12:00pm-1:30pm

Comparison of DAT scan, cardiac MIBG scintigraphy, and cerebrospinal fluid 5HIAA levels in Parkinsonian syndrome

R. Sengoku, M. Yamazaki, D. Kaneda, Y. Nishina, A.M. Tokumaru, S. Murayama (Tokyo, Japan)

12:00pm-1:30pm

Corpus callosum thickness and area in Parkinson’s disease

I.O. Bledsoe, D. Merkitch, G. Stebbins, B. Bernard, J.G. Goldman (Chicago, IL, USA)

12:00pm-1:30pm

Correlation analysis for postural instability and autonomic dysfunction in patients with Parkinson’s disease

S. You, S.H. Lim, H. Lee, H.A. Kim (Dague, Korea)

12:00pm-1:30pm

Cortical atrophy in cognitively impaired Parkinson’s disease patients

M.M. Almuqbel, T.R. Melzer, D.J. Myall, M.R. MacAskill, L. Livingston, K. Wood, T.L. Pitcher, R.J. Keenan, J.C. Dalrymple-Alford, T.J. Andrson (Christchurch, New Zealand)

12:00pm-1:30pm

Cortical excitability in patients with Parkinson’s disease on levodopa carbidopa intestinal gel thereapy

S.D. Kim, S. Vucic, N. Mahant, M.C. Kiernan, V.S.C. Fung (Sydney, Australia)

12:00pm-1:30pm

Cortical phase amplitude coupling (PAC) identifies patterns in clinical states of Parkinson’s disease (PD) using magnetoencephalography (MEG)

E. Peña, S.A. Mian, L. Rosedahl, F.A.I. Mohammed, T.M. Mohammad, M.D. Johnson, J.A. Bajwa (Minneapolis, MN, USA)

12:00pm-1:30pm

Cortical thinning associated with mild cognitive impairment in Parkinson’s disease

S. Galantucci, F. Agosta, T. Stojkovic, I. Petrovic, E. Stefanova, E. Canu, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)

12:00pm-1:30pm

Critical path for Parkinson’s II: Global regulatory agencies support the use of dopamine transporter neuroimaging as an enrichment biomarker to enable clinical trials in early Parkinson’s disease

D.T. Stephenson, S. Arneric, D. Babcock, P. Cole, T. Comery, M.F. Gordon, D. Grosset, D. Hill, S.Z. Imam, C.R. Jarecke, V. Kern, D. Matthews, R. Meibach, K. Romero, A. Roach, D. Russell, J. Seibyl, P. Sherwin, B.A. Sieber, L. Slicker, C. Sur, K. Marek (Tucson, AZ, USA)

12:00pm-1:30pm

DAT SPECT data of Parkinson’s disease patients with and without REM Sleep Pathology: A report from the DeNoPa cohort

M.L. Muntean, D. Leucuta, B. Mollenhauer, C. Trenkwalder, F. Sixel-Döring (Göttingen, Germany)

12:00pm-1:30pm

Density of metabotropic glutamate receptors subtype 1 in de novo patients with Parkinson’s disease using ¹¹C-ITMM PET

M. Mishina, M. Suzuki, K. Ishii, M. Sakata, K. Wagetsuma, K. Ishibashi, J. Toyohara, M.R. Zhang, K. Kimura, K. Ishiwata (Kawasaki, Japan)

12:00pm-1:30pm

Detecting brainstem changes in Parkinson’s disease using quantitative MRI

C. Lambert, A. Lutti, B. Draganski, T. Foltynie (London, United Kingdom)

12:00pm-1:30pm

Detection of primary olfactory cortex dysfunction in early-stage Parkinson’s disease

J. Wang, T. Subramanian, Q.X. Yang (Hershey, PA, USA)

12:00pm-1:30pm

Diagnostic reliability of clinical symptoms in patients with incomplete manifestation of the triad of parkinsonism compared to 18F-DOPA PET-CT MRI imaging

C. Peralta, T. Soto Depetris, A. Perez, F. Biafore, J. Gili, A. Valda, D. Menna, M. Aguilar, H. Corradini, M. Bastianello (Caba, Argentina)

12:00pm-1:30pm

Diffusion tensor imaging in Parkinson’s disease: Review and meta-analysis with clinical considerations and neuroimaring parameters

C. Atkinson-Clement, S. Pinto, A. Eusebio, O. Coulon (Aix-en-Provence, France)

12:00pm-1:30pm

Diffusion tensor imaging of corticospinal tract, cingulum and corpus callosum in Parkinson’s disease (PD) patients

R. Guimarães, B. Campos, L. Campos, L. Piovesana, P. Azevedo, A. D'Abreu, F. Cendes (Campinas, Brazil)

12:00pm-1:30pm

Diffusion tensor imaging of the corticospinal tract differentiates Parkinson’s disease (PD) patients from controls

R. Guimaraes, B. Campos, L. Campos, L. Piovesana, P. Azevedo, A. D'Abreu, F. Cendes (Campinas, Brazil)

12:00pm-1:30pm

Diffusion tensor metrics of thalamic degeneration and postural instability in Parkinson’s disease

M. Petrou, C. Davatzikos, M. Muller, R. Koeppe, R. Albin, K. Frey, N. Bohnen (Ann Arbor, MI, USA)

12:00pm-1:30pm

Disrupted hubs in functional brain networks in subtype-specific Parkinson’s disease

L. Ma, H. Chen, T. Feng (Beijing, People's Republic of China)

12:00pm-1:30pm

Disrupted motor memory in Parkinson’s disease

S. Voets, J.S. Brittain, M. Panouilleres, C. Miall, N. Jenkinson (Birmingham, United Kingdom)

12:00pm-1:30pm

Disruption of functional connectivity in Parkinson’s disease patients presenting phonemic fluency impairment

K. Kawabata, H. Watanabe, E. Bagarinao, N. Yoneyama, K. Hara, R. Ohdake, K. Imai, M. Masuda, T. Yokoi, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)

12:00pm-1:30pm

Does dopamine affect the selection of stepping actions in PD?

E. Mallia, C. Stummer, J. Rothwell, B.R. Bloem, V. Weerdesteyn (London, United Kingdom)

12:00pm-1:30pm

Dopamine and task-dependent evolution of oscillatory activity in the subthalamic nucleus (STN) and coupling between the STN local field potential and muscle activity in Parkinson’s disease

U. Ramirez Pasos, R. Reese, F. Steigerwald, M. Reich, C. Matthies, I. Isaias, J. Volkmann (Wuerzburg, Germany)

12:00pm-1:30pm

Dopamine reduces Parkinson’s tremor through increased thalamic inhibition

M.F. Dirkx, H.E. den Ouden, E. Aarts, M. Timmer, B.R. Bloem, I. Toni, R.C. Helmich (Nijmegen, Netherlands)

12:00pm-1:30pm

Dopaminergic and metabolic network activities in onset-related subtypes of Parkinson’s disease: A dual-tracer positron emission tomography study

F.T. Liu, J.J. Ge, J.J. Wu, Z.T. Ding, C.T. Zuo, J. Wang (Shanghai, People's Republic of China)

12:00pm-1:30pm

Dopaminergic medication affects choice bias in Parkinson’s disease

A.J.M. van Nuland, R.C.G. Helmich, M. Dirkx, H. Zach, B.R. Bloem, I. Toni, R. Cools, H.E.M. den Ouden (Nijmegen, Netherlands)

12:00pm-1:30pm

DTI in Parkinson’s disease: Asymmetric progression

L. Chan, K. Ng, C. Yeoh, H. Rumpel, E. Tan (Singapore, Singapore)

12:00pm-1:30pm

Dynamic dopamine transporter images are helpful for diagnosing parkinsonism

K. Abe, K. Fukushima, T. Katuura, K. Kitajima, Y. Maeda, K. Hahiskawa, H. Yoshikawa (Nishinomiya, Japan)

12:00pm-1:30pm

Effectiveness of Levodopa responsiveness of Blink reflex recovery: An objective method to differentiate Parkinsonian syndromes

C. Gaddipati, M. Umaiorubahan, C.U. Velmurugendran, V. Shankar (Chennai, India)

12:00pm-1:30pm

Evaluating quantitative EEG (QEEG) measures to differentiate between Parkinson’s disease (PD) patients and healthy individuals

M. Chaturvedi, F. Hatz, U. Gschwandtner, V. Roth, P. Fuhr (Basel, Switzerland)

12:00pm-1:30pm

Excessive daytime sleepiness is mediated by loss of caudate dopaminergic function in Parkinson’s disease

T. Yousaf, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

12:00pm-1:30pm

Exploring structural covariance networks of gray matter in Parkinson’s disease

L.J. de Schipper, J. van der Grond, J. Marinus, J.J. van Hilten (Leiden, Netherlands)

12:00pm-1:30pm

Freezing of gait (FOG) in PD: Is electroencephalography (EEG) a gateway to elucidating the pathophysiology?

T. Munteanu, E.J. Baird, C. Fearon, S.M. Waechter, C. McDonnell, J. Gallego, B. Quinlivan, I. Killane, J.S. Butler, T. Lynch, R.B. Reilly (Dublin, Ireland)

12:00pm-1:30pm

Frontal cortex grey matter integrity determines motor improvement after STN-DBS in patients with Parkinson’s disease

M. Muthuraman, G. Deuschl, C. Riedel, J. Volkmann, S. Groppa (Mainz, Germany)

12:00pm-1:30pm

Functional connectivity alterations in Parkinson’s disease patients with impulsive control disorders

A. Campabadal, B. Segura, H.C. Baggio, M.J. Marti, F. Valldeoriola, Y. Compta, C. Uribe, A.I. Garcia-Diaz, A. Abos, C. Junque (Barcelona, Spain)

12:00pm-1:30pm

Functional connectivity underpinnings of fatigue in “drug-naïve” patients with Parkinson’s disease

A. Giordano, R. De Micco, G. Caiazzo, A. Russo, M. Cirillo, F. Esposito, G. Tedeschi, A. Tessitore (Naples, Italy)

12:00pm-1:30pm

Functional connectome organization is altered in PD patients with mild cognitive impairment

S. Galantucci, F. Agosta, I. Stankovic, S. Basaia, T. Stojkovic, E. Stefanova, E. Canu, A. Meani, V.S. Kostic, M. Filippi (Milan, Italy)

12:00pm-1:30pm

Functional deficits during response inhibition improve after dopaminergic medication for Parkinson

C. Vriend, J.P. Trujillo, N.J.H.M. Gerrits, H.W. Berendse, Y.D. van der Werf, O.A. van den Heuvel (Amsterdam, Netherlands)

12:00pm-1:30pm

Gray/white matter contrast loss correlates with clinical severity and visuospatial impairment in Parkinson’s disease patients

C. Uribe, B. Segura, H.C. Baggio, M.J. Marti, F. Valldeoriola, Y. Compta, A.I. Garcia-Diaz, A. Campabadal, A. Abos, C. Junque (Barcelona, Spain)

12:00pm-1:30pm

How does preprocessing affect estimation of causal information transfer in the human brain?

I. Weber, E. Florin, F. Jung, M. von Papen, L. Timmermann (Cologne, Germany)

12:00pm-1:30pm

Impact of chronic LD treatment on metabolism, blood flow and blood-brain barrier permeability in the 6-OHDA rat model

R.P. Lerner, Z. Bimpisidis, V. Jourdain, T. Chaly, M. Hellman, K. Graf, V. Dhawan, S. Dewey, A. Cenci, D. Eidelberg (Manhasset, NY, USA)

12:00pm-1:30pm

Impact of datscan on clinical decision making: diagnosis and management of clinically uncertain Parkinsonian syndromes

J.R. Isaacson, N. Chhabria, S.H. Isaacson (Boca Raton, FL, USA)

12:00pm-1:30pm

Impact of white matter hyperintensity on motor compensation in Parkinson’s disease

J.J. Lee, Y. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Korea)

12:00pm-1:30pm

Impaired cerebellum to motor cortex associative plasticity in Parkinson’s disease

M.K. Lu, C.M. Chen, J.R. Duann, C.H. Tsai (Taichung, Taiwan)

12:00pm-1:30pm

Impaired temporal coupling of action and perception in Parkinson’s disease

E. Pretegiani, N. Vanegas-Arroyave, E. FitzGibbon, M. Hallett, L.M. Optican (Bethesda, MD, USA)

12:00pm-1:30pm

Improvement of saccade amplitude by the STN DBS and visual target eccentricity

A. Yugeta, Y. Terao, Y. Ugawa (Tokyo, Japan)

12:00pm-1:30pm

Increased cortical control of gait in patients with Parkinson’s disease and freezing of gait

G.J. Revuelta, C. Chan, S. Jenkins, J. Jensen, L. Bonilha (Charleston, SC, USA)

12:00pm-1:30pm

Inferring the coupling of motor related brain areas during paced finger tapping in Parkinson’s patients

V. Seeger, F. Jung, L. Schneider, T.A. Dembek, P. Reker, N. Apetz, M. Tittgemeyer, L. Timmermann (Cologne, Germany)

12:00pm-1:30pm

Influence of different spike sorting algorithms on the detection of single unit spiking activity in the subthalamic nucleus of patients with Parkinson’s disease

J. Sukiban, R. Pauli, T.A. Dembek, I. Weber, F. Jung, N. Voges, M. Denker, S. Gruen, L. Timmermann (Cologne, Germany)

12:00pm-1:30pm

Influence of lateral wedges on postural control in patient with Parkinson’s disease

J. Park, J. Yoon, W. Jang, J.S. Kim, J. Youn, E.S. Oh (Busan, Korea)

12:00pm-1:30pm

Intraoperative localization of beta band and high-frequency oscillations within the subthalamic nucleus

B.C.M. van Wijk, A. Pogosyan, T. Foltynie, M.I. Hariz, P. Limousin, L. Zrinzo, P. Brown, V. Litvak (London, United Kingdom)

12:00pm-1:30pm

Is it just a coincidence? Three new cases of Parkinson’s disease associated with myasthenia gravis

G. Sciacca, A. Nicoletti, E. Reggio, G. Mostile, M. Zappia (Catania, Italy)

12:00pm-1:30pm

Is the defective gait automaticity associated to deficiencies in implicit learning in patients with Parkinson’s disease?

M.E.P. Piemonte, A.F. Helene, B. Monte, E.N. Guelfi, E. Okamoto, C. Vargas, J.A. Galves (Sao Paulo, Brazil)

12:00pm-1:30pm

Is the selection of stepping impaired in PD in ON state?

C. Stummer, E. Mallia, J. Rothwell, B.R. Bloem, V. Weerdesteyn (Nijmegen, Netherlands)

12:00pm-1:30pm

Lessons-experienced in the creation of a global public-private consortium with the goal of advancing treatments that hold most potential for delayed disease progression in Parkinson’s disease – Critical path for Parkinson’s (CPP)

V.D. Kern, D.T. Stephenson, K. Romero, E. Avilés, S.T. Broadbent, S.P. Arneric, L. Barbieri, S. Ford, A. Roach (Tucson, AZ, USA)

12:00pm-1:30pm

Magnetic resonance imaging of nigrosome-1 in the diagnosis of early Parkinson’s: Initial results of the Parkinson’s magnetic imaging repository (PaMIR)

S.T. Schwarz, Y. Xing, A. Martin Bastida, C. Lakmali Sugathapala, M. Silverdale, J. Mclean, R. Jampana, N. Bajaj, D. Burn, P. Piccini, D. Grosset, D.P. Auer (Nottingham, United Kingdom)

12:00pm-1:30pm

May substantia nigra volume asymmetry be an indicator of motor asymmetry in Parkinson’s disease? A retrospective analysis

N.F. Durmaz, M. Yorubulut, C.M. Akbostanci (Ankara, Turkey)

12:00pm-1:30pm

Metabolic brain changes related to specific cognitive impairment in non-demented Parkinson’s disease patients

M. Trošt, S. Brezovar, C.C. Tang, D. Eidelberg, N. Zupancic Kriznar, M. Gregoric Kramberger, P. Tomše, Z. Pirtošek (Ljubljana, Slovenia)

12:00pm-1:30pm

Modulation of local field potentials during gait in the STN of patients with Parkinson’s disease

F. Hell, J.H. Mehrkens, A. Plate, K. Bötzel (München, Germany)

12:00pm-1:30pm

Motor subtypes in Parkinson’s disease are distinguished by alterations in morphology and white matter integrity

G. Vervoort, I. Leunissen, M. Firbank, E. Heremans, E. Nackaerts, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)

12:00pm-1:30pm

Movement related beta oscillatory activity during self-paced wrist movement in the human subthalamic nucleus

P. Zhuang, R. Chen, M. Hallett, Q. Cui, Y. Zhang, J. Li, Y. Li (Beijing, People's Republic of China)

12:00pm-1:30pm

MRI signatures of the brain of Parkinson’s disease and idiopathic REM sleep behavioral disorder subjects

P. Tuite, S. Mangia, P. Burton, A. Svatkova, I. Nestrasil, A. Sierra Lopez, K. Shmueli, L. Eberly, M. Howell, S. Michaeli (Minneapolis, MN, USA)

12:00pm-1:30pm

Multi-modal imaging in Parkinson’s disease patients with freezing of gait

J.M. Hall, C. O'Callaghan, J.M. Shine, M. Gilat, C.C. Walton, K.A. Ehgoetz Martens, A.A. Moustafa, S.J.G. Lewis (Milperra, Australia)

12:00pm-1:30pm

Negative emotional signals impair isometric force control in Parkinson’s disease

R.L. Blakemore, M.R. MacAskill, R. Shoorangiz, T.J. Anderson (Christchurch, New Zealand)

12:00pm-1:30pm

Neural mechanisms underlying step initiation failure in patients with Parkinson’s disease and freezing of gait

M. Gilat, M. Georgiades, J.M. Shine, K.A. Ehgoetz Martens, C.C. Walton, J.M. Hall, S.J.G. Lewis (Sydney, Australia)

12:00pm-1:30pm

Neural substrates of excessive daytime sleepiness in early drug naïve Parkinson’s disease: A resting state functional MRI study

M.C. Wen, S.Y.E. Ng, H.S.E. Heng, Y. Chao, L.L. Chan, E.K. Tan, L.C.S. Tan (Singapore, Singapore)

12:00pm-1:30pm

Neuromelanin-MRI of substantia nigra subregions in Parkinson’s disease

L. Borellini, G. Franco, P. Trujillo, P. Summers, A. Di Fonzo, D.O. Claassen, A. Costa (Milan, Italy)

12:00pm-1:30pm

Nigrostriatal degeneration and serum BDNF levels in patients with “de novo” untreated Parkinson’s disease

G. Marti, N. Saez, M. Corominas, G. Cuberas, C. Lorenzo, O. De Fabregues, J. Alvarez-Sabin, M. Casas, J. Hernandez (Barcelona, Spain)

12:00pm-1:30pm

Novel PET Tracers of alpha-synuclein for the diagnosis of Parkinson’s disease

E. Tsika, A. Davranche, J. Molette, E. Gabellieri, S. Papin, S. Nampally, H. Kroth, D. Lowe, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

12:00pm-1:30pm

Olfactory performance and resting state functional connectivity in non-demented drug naïve patients with Parkinson’s disease

M. Sunwoo, J.H. Ham, J.Y. Hong, Y.H. Sohn, P.H. Lee (Seongnam, Korea)

12:00pm-1:30pm

Onset-related subtypes of Parkinson’s disease differ in the patterns of striatal functional connectivity: A resting-state functional MRI study

Y. Hou, J. Yang, C. Luo, R. Ou, W. Song, Q. Gong, H. Shang (Chengdu, People's Republic of China)

12:00pm-1:30pm

Pain-motor integration in the primary motor cortex in Parkinson’s disease

A. Suppa, C. Leone, F. Di Stasio, A. Biasiotta, L. Marsili, S. La Cesa, A. Di Santo, G. Fabbrini, G. Cruccu, A. Berardelli (Rome, Italy)

12:00pm-1:30pm

Pallidal DBS and pallidotomy alter cortical synchronization in Parkinson’s disease

S. Miocinovic, C. De Hemptinne, A. Miller, J.L. Ostrem, P.A. Starr (San Francisco, CA, USA)

12:00pm-1:30pm

Parkinson’s disease-linked mutation in DNAJC13 causes specific trafficking defect in endosomal pathway

S. Yoshida, T. Hasegawa, R. Oshima, J. Kobayashi, N. Sugeno, A. Kikuchi, A. Takeda, M. Aoki (Sendai, Japan)

12:00pm-1:30pm

Prognostic factors of motor symptoms in Parkinson’s disease using neuromelanin imaging and the relationship with (123)I-FP-CIT-SPECT

A. Okuzumi, T. Hatano, K. Kamagata, M. Hori, S. Aoki, N. Hattori (Tokyo, Japan)

12:00pm-1:30pm

Progressive atrophy of parahippocampal gyrus correlates with Hoehn & Yahr stages of Parkinson’s disease: A voxel based morphometric study

P.K. Pal, R.M. Naduthota, L. George, K. Jhunjhunwala, J. Saini, R.D. Bharath, A. Lenka, R. Yadav (Bangalore, India)

12:00pm-1:30pm

Pronounced beta oscillations are a characteristic of the cortico-basal ganglia loop of subacute and chronic animal models of Parkinson´s disease

C. van Riesen, J.K. Haumesser, J. Kühn, A. Kühn, M.H. Beck (Berlin, Germany)

12:00pm-1:30pm

Recruitment of single subthalamic neurons for kinematic control of hand and feet movements employs different strategies

A. Tankus, A. Mirelman, N. Giladi, I. Fried, J.M. Hausdorff (Tel-Aviv, Israel)

12:00pm-1:30pm

Relation between the clinical features and the standardized heart to mediastinum ratio in cardiac metaiodobenzylguanidine imaging in patients with Parkinson’s disease: A multicenter cross-sectional study

T. Osada, Y. Morita, K. Ohta, S. Nogawa, K. Takahashi, K. Yamaguchi, D. Yasutomi, M. Seki, Y. Nihei, S. Iwasawa, N. Suzuki (Tokyo, Japan)

12:00pm-1:30pm

Relationship between freezing and pedunculopontine nucleus’ size in Parkinson’s disease: Semi quantitative analysis based on MRI with modified FGATIR sequence

S. Chen, M. Tir, P. Monet, J.M. Constans, O. Godefroy, M. Lefranc, P. Krystkowiak (Amiens, France)

12:00pm-1:30pm

Research of vestibular evoked myogenic potentials (VEMP) in the diagnosis of postural instability in Parkinson’s disease

O.A. Alenicova, S.A. Likhachev (Minsk, Belarus)

12:00pm-1:30pm

Resting state functional connectivity in olfactory network in de novo Parkinson’s disease

S. Marino, L. Bonanno, F. Caminiti, F. Corallo, V. Lo Buono, S. De Salvo, G. Di Lorenzo, P. Bramanti (Messina, Italy)

12:00pm-1:30pm

Resting-state functional connectivity of subthalamic nucleus in different phenotypes of Parkinson’s disease

Z. Wang, H. Chen, H. Ma, L. Ma, T. Wu, T. Feng (Beijing, People's Republic of China)

12:00pm-1:30pm

Sensory and motor aspects of rhythmic entrainment in Parkinson’s disease

E.S. te Woerd, R. Oostenveld, F.P. de Lange, P. Praamstra (Nijmegen, Netherlands)

12:00pm-1:30pm

Spectral analysis of rapid eye movement (REM) sleep as a potential marker of neurodegenerative disease in REM sleep behavior disorder

J. Rodrigues Brazète, J.F. Gagnon, R.B. Postuma, P.A. Bourgouin, D. Petit, J. Montplaisir (Montreal, QC, Canada)

12:00pm-1:30pm

Substantia nigra hyperechogenicity in Mexican patients with Parkinson’s disease

C.Y. Rodriguez-Garza, A. Anaya-Escamilla, R. Pinales-Razo, I. Estrada-Bellmann, C.R. Camara-Lemarroy (Monterrey, Mexico)

12:00pm-1:30pm

Substantia nigra hyperechogenicity in Parkinson´s disease motor phenotypes

T. Toomsoo, A.H. Pool, I. Liepelt–Scarfone, L. Kadastik-Eerme, T. Asser, D. Berg, P. Taba (Tallinn, Estonia)

12:00pm-1:30pm

Suppression of dyskinesia in Parkinson’s disease by electrical stimulation of dorsal subthalamic nucleus tissue

H.A.C. Wark, G.H. Duffley, C.R. Butson, L.E. Schrock (Salt Lake City, UT, USA)

12:00pm-1:30pm

Targeted over-expression with AAV-mediated human α-synuclein in a rat model of Parkinson’s disease – Validation of novel fine motor functional effects

R. Pussinen, T. Ahtoniemi, T. Huhtala, O. Kontkanen, A. Nurmi (Kuopio, Finland)

12:00pm-1:30pm

The association between structural brain connectivity with plasma APO-A1 levels in Parkinson’s disease: Connectometry approach

F. Rahmani, M.H. Aarabi (Tehran, Islamic Republic of Iran)

12:00pm-1:30pm

The effect of an eight-week mindfulness training intervention on emotion related brain activation in people with Parkinson’s disease

B.A. Pickut, W. Van Hecke, P. Cras, E. Kerckhofs, S. Vanneste, D. Crosiers, P. Marien, P.M. Parizel (Grand Rapids, MI, USA)

12:00pm-1:30pm

The effect of dopaminergic therapy on stimulus-response learning and decision-making in Parkinson’s disease using fMRI

P.A. MacDonald, N.M. Hiebert, K.N. Seergobin, A.M. Owen (London, ON, Canada)

12:00pm-1:30pm

The efficacy of quantitative ^99mTc-TRODAT-1 SPECT in diagnosis of aged patients with Parkinson’s disease

C.F. Lee, C.Y. Wei, G.U. Huang, I.J. Chen, B. Hsu (Changhua, Taiwan)

12:00pm-1:30pm

The feasibility of measuring fatigability in early-stage Parkinson’s disease using functional MRI

Y. Xing, N. Bajaj, S.T. Schwarz, D.P. Auer (Nottingham, United Kingdom)

12:00pm-1:30pm

The patient’s perspective: The effect of dopamine on Parkinson symptoms

H. Zach, M.F. Dirkx, J.W. Pasman, B.R. Bloem, R.C. Helmich (Vienna, Austria)

12:00pm-1:30pm

The position of the conus medullaris and the prevalence of isolated lipoma of filum terminale in Parkinson’s disease

H. Mori, K. Shindo (Kurashiki, Japan)

12:00pm-1:30pm

The relationship among clinical features, DAT scintigraphy and MIBG cardiac scintigraphy in patients with Parkinson’s disease

J. Ebina, T. Sekiguchi, M. Takahashi, A. Inaba, S. Orimo (Tokyo, Japan)

12:00pm-1:30pm

The role of cathepsin L involved in the activation of microglia and Parkinson’s disease

S. Xu, X. Yang, H. Zhang, Y. Qian, Q. Xiao (Shanghai, People's Republic of China)

12:00pm-1:30pm

The role of striatal dopaminergic terminals in early de novo PD patients with speech impairment

S. Polychronis, G. Pagano, M. Politis (London, United Kingdom)

12:00pm-1:30pm

The role of the frontal lobe in complex walking among healthy older adults and patients with Parkinson’s disease: An fNIRS study

A. Mirelman, I. Maidan, F. Nieuwhof, H. Bernad-Elazari, M.F. Reelick, B.R. Bloem, N. Giladi, J.E. Deutsch, J.A.H.R. Claassen, J.M. Hausdorff (Tel Aviv, Israel)

12:00pm-1:30pm

Tracking Parkinson’s disease over 2-6 years with MRI

T.R. Melzer, D.J. Myall, M.R. MacAskill, L. Livingston, T.L. Pitcher, K. Wood, R.J. Keenan, J.C. Dalrymple-Alford, T.J. Anderson (Christchurch, New Zealand)

12:00pm-1:30pm

Transcranial sonography of the substantia nigra and its correlation with iron metabolism and c-reactive protein in Parkinson’s disease

X. Yang, J. Liu, Y. Qian, S. Xu, Q. Xiao (Shanghai, People's Republic of China)

12:00pm-1:30pm

Transcranial static magnetic field stimulation (tSMS) decreases motor cortex excitability in Parkinson’s disease OFF but not ON medication

M. Dileone, M. Carrasco-López, J. Segundo-Rodriguez, L. Mordillo-Mateos, N. López-Aristegui, F. Alonso-Frech, M. Catalan-Alonso, J. Obeso, A. Oliviero, G. Foffani (Madrid, Spain)

12:00pm-1:30pm

Ultra high field magnetic resonance imaging of nigrosome 1 is a biomarker of new onset and premotor Parkinson’s disease

M.A. Brodsky, J.M. Pollock, J. Grinstead, D. Lahna, D. Pettersson, W.D. Rooney (Portland, OR, USA)

12:00pm-1:30pm

Vestibular evoked myogenic potentials as biomarkers for non-motor symptoms of Parkinson’s disease

A. Shalash, D. Hassan (Cairo, Egypt)

12:00pm-1:30pm

Visual hallucination and pattern of brain degeneration in Parkinson’s disease

W.W. Lee, E.J. Yoon, J.Y. Lee, S.W. Park, Y.K. Kim (Seoul, Korea)

12:00pm-1:30pm

Visual vs. automated analysis of [123I]FP-CIT SPECT scans in patients with parkinsonism

E. Mäkinen, J. Joutsa, J. Johansson, M. Mäki, M. Seppänen, V. Kaasinen (Turku, Finland)

12:00pm-1:30pm

What predicts Parkinson’s disease? Hyposmia, MIBG SPECT, DAT SPECT and the PD-specific metabolic pattern

S.K. Meles, D. Vadasz, R.J. Renken, K.M. Eggert, E. Sittig-Wiegand, C. Depboylu, V. Ries, G. Mayer, K. Reetz, S. Overeem, A. Pijpers, H. Höffken, M. Luster, K. Kesper, W. Oertel, K.L. Leenders (Groningen, Netherlands)